from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2045c/lipT

LFCtreatmentdescriptionclass of inhibitor

-0.283

Amikacinug/mL Amikacintranslation

-1.705

Cap5-10ug/mL Capreomycintranslation

-1.376

Rox10-50 ug/mL Roxithromycintranslation

0.204

SM2-5 ug/mL Streptomycintranslation

-0.114

Tet5-10 ug/mL Tetracyclinetranslation

0.487

Rif0.2-5ug/mL Rifampicintranscription

-0.674

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.626

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.671

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.611

CPZ10-50 ug/mL Chlorpromazinerespiration

0.099

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.388

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.680

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.330

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.035

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.408

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.283

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.525

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.351

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.141

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.583

KCN5-20 ug/mL Potassium cyaniderespiration

-0.600

NaN30.2-2 mM Sodium aziderespiration

0.459

Nigericin50 uM Nigericinrespiration

0.582

TRC10-150 ug/mL Triclosanrespiration

0.842

TRZ10-25 ug/mL Thioridazinerespiration

-0.061

Valinomycin0.5-10 uM Valinomycinrespiration

1.841

ZnSO42 mM ZnSO4respiration

0.453

menadione6-10 ug/mL Menadionerespiration

0.131

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.349

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.201

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.372

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.156

NRP_1Non-replicating persistence stage 1dosRassociated

0.275

Amp0.2mg/mL AmpicillincellWall

-0.128

Cephalexin20-100 ug/mL CephalexincellWall

-0.434

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.038

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.063

EMB10-20 ug/mL EthambutolcellWall

0.317

Eta12-40 ug/mL EthionamidecellWall

-0.184

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.212

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.505

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.457

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.290

BZA0.12 mg/mL BenzamidearomaticAmides

-0.093

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.389

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.309

H2O24 mM hydrogen peroxideDNAdamaging

-0.172

Levo10 ug/mL LevofloxacinDNAdamaging

-0.219

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.905

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.273

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.149

UVUV-irradiationDNAdamaging

1.101

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.105

Antimycin12.5-50 ug/mL Antimycin A?

1.051

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.368

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.606

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.845

PA8240.2-2 ug/mL PA-824?

-0.624

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.412

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.204

Verapamil50 uM Verapamil?

-0.285

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.265

methoxatin10-20 ug/mL Methoxatin?